Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
17,797
archived clinical trials in
Peripheral Vascular Disease

Supporting Patients Undergoing HIgh-Risk PCI Using a High-Flow PErcutaneous Left Ventricular Support Device (SHIELD II)
Supporting Patients Undergoing HIgh-Risk PCI Using a High-Flow PErcutaneous Left Ventricular Support Device (SHIELD II)
Status: Enrolling
Updated:  12/31/1969
Ochsner Medical Center
mi
from
New Orleans, LA
Supporting Patients Undergoing HIgh-Risk PCI Using a High-Flow PErcutaneous Left Ventricular Support Device (SHIELD II)
Supporting Patients Undergoing HIgh-Risk PCI Using a High-Flow PErcutaneous Left Ventricular Support Device (SHIELD II)
Status: Enrolling
Updated: 12/31/1969
Ochsner Medical Center
mi
from
New Orleans, LA
Click here to add this to my saved trials
Supporting Patients Undergoing HIgh-Risk PCI Using a High-Flow PErcutaneous Left Ventricular Support Device (SHIELD II)
Supporting Patients Undergoing HIgh-Risk PCI Using a High-Flow PErcutaneous Left Ventricular Support Device (SHIELD II)
Status: Enrolling
Updated:  12/31/1969
Tufts Medical Center
mi
from
Boston, MA
Supporting Patients Undergoing HIgh-Risk PCI Using a High-Flow PErcutaneous Left Ventricular Support Device (SHIELD II)
Supporting Patients Undergoing HIgh-Risk PCI Using a High-Flow PErcutaneous Left Ventricular Support Device (SHIELD II)
Status: Enrolling
Updated: 12/31/1969
Tufts Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
Supporting Patients Undergoing HIgh-Risk PCI Using a High-Flow PErcutaneous Left Ventricular Support Device (SHIELD II)
Supporting Patients Undergoing HIgh-Risk PCI Using a High-Flow PErcutaneous Left Ventricular Support Device (SHIELD II)
Status: Enrolling
Updated:  12/31/1969
ST. Luke's Hospital
mi
from
Kansas City, MO
Supporting Patients Undergoing HIgh-Risk PCI Using a High-Flow PErcutaneous Left Ventricular Support Device (SHIELD II)
Supporting Patients Undergoing HIgh-Risk PCI Using a High-Flow PErcutaneous Left Ventricular Support Device (SHIELD II)
Status: Enrolling
Updated: 12/31/1969
ST. Luke's Hospital
mi
from
Kansas City, MO
Click here to add this to my saved trials
Supporting Patients Undergoing HIgh-Risk PCI Using a High-Flow PErcutaneous Left Ventricular Support Device (SHIELD II)
Supporting Patients Undergoing HIgh-Risk PCI Using a High-Flow PErcutaneous Left Ventricular Support Device (SHIELD II)
Status: Enrolling
Updated:  12/31/1969
Barnes Jewish Hospital
mi
from
Saint Louis, MO
Supporting Patients Undergoing HIgh-Risk PCI Using a High-Flow PErcutaneous Left Ventricular Support Device (SHIELD II)
Supporting Patients Undergoing HIgh-Risk PCI Using a High-Flow PErcutaneous Left Ventricular Support Device (SHIELD II)
Status: Enrolling
Updated: 12/31/1969
Barnes Jewish Hospital
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Supporting Patients Undergoing HIgh-Risk PCI Using a High-Flow PErcutaneous Left Ventricular Support Device (SHIELD II)
Supporting Patients Undergoing HIgh-Risk PCI Using a High-Flow PErcutaneous Left Ventricular Support Device (SHIELD II)
Status: Enrolling
Updated:  12/31/1969
Atlantic Health System - Morristown Memorial Hospital
mi
from
Morristown, NJ
Supporting Patients Undergoing HIgh-Risk PCI Using a High-Flow PErcutaneous Left Ventricular Support Device (SHIELD II)
Supporting Patients Undergoing HIgh-Risk PCI Using a High-Flow PErcutaneous Left Ventricular Support Device (SHIELD II)
Status: Enrolling
Updated: 12/31/1969
Atlantic Health System - Morristown Memorial Hospital
mi
from
Morristown, NJ
Click here to add this to my saved trials
In-Stent Restenosis Post-Approval Study
Post-Approval Study of the GORE® VIABAHN® Endoprosthesis for the Treatment of In-Stent Restenosis (ISR) in the Superficial Femoral Artery (SFA)
Status: Enrolling
Updated:  12/31/1969
Cardiovascular Institute of the South
mi
from
Houma, LA
In-Stent Restenosis Post-Approval Study
Post-Approval Study of the GORE® VIABAHN® Endoprosthesis for the Treatment of In-Stent Restenosis (ISR) in the Superficial Femoral Artery (SFA)
Status: Enrolling
Updated: 12/31/1969
Cardiovascular Institute of the South
mi
from
Houma, LA
Click here to add this to my saved trials
In-Stent Restenosis Post-Approval Study
Post-Approval Study of the GORE® VIABAHN® Endoprosthesis for the Treatment of In-Stent Restenosis (ISR) in the Superficial Femoral Artery (SFA)
Status: Enrolling
Updated:  12/31/1969
Greenville Hospital System
mi
from
Greenville, SC
In-Stent Restenosis Post-Approval Study
Post-Approval Study of the GORE® VIABAHN® Endoprosthesis for the Treatment of In-Stent Restenosis (ISR) in the Superficial Femoral Artery (SFA)
Status: Enrolling
Updated: 12/31/1969
Greenville Hospital System
mi
from
Greenville, SC
Click here to add this to my saved trials
In-Stent Restenosis Post-Approval Study
Post-Approval Study of the GORE® VIABAHN® Endoprosthesis for the Treatment of In-Stent Restenosis (ISR) in the Superficial Femoral Artery (SFA)
Status: Enrolling
Updated:  12/31/1969
Cardiology Associates of Mobile, Inc.
mi
from
Fairhope, AL
In-Stent Restenosis Post-Approval Study
Post-Approval Study of the GORE® VIABAHN® Endoprosthesis for the Treatment of In-Stent Restenosis (ISR) in the Superficial Femoral Artery (SFA)
Status: Enrolling
Updated: 12/31/1969
Cardiology Associates of Mobile, Inc.
mi
from
Fairhope, AL
Click here to add this to my saved trials
In-Stent Restenosis Post-Approval Study
Post-Approval Study of the GORE® VIABAHN® Endoprosthesis for the Treatment of In-Stent Restenosis (ISR) in the Superficial Femoral Artery (SFA)
Status: Enrolling
Updated:  12/31/1969
Rockford Cardiovascular Associates
mi
from
Rockford, IL
In-Stent Restenosis Post-Approval Study
Post-Approval Study of the GORE® VIABAHN® Endoprosthesis for the Treatment of In-Stent Restenosis (ISR) in the Superficial Femoral Artery (SFA)
Status: Enrolling
Updated: 12/31/1969
Rockford Cardiovascular Associates
mi
from
Rockford, IL
Click here to add this to my saved trials
In-Stent Restenosis Post-Approval Study
Post-Approval Study of the GORE® VIABAHN® Endoprosthesis for the Treatment of In-Stent Restenosis (ISR) in the Superficial Femoral Artery (SFA)
Status: Enrolling
Updated:  12/31/1969
Munson Medical Center
mi
from
Traverse City, MI
In-Stent Restenosis Post-Approval Study
Post-Approval Study of the GORE® VIABAHN® Endoprosthesis for the Treatment of In-Stent Restenosis (ISR) in the Superficial Femoral Artery (SFA)
Status: Enrolling
Updated: 12/31/1969
Munson Medical Center
mi
from
Traverse City, MI
Click here to add this to my saved trials
In-Stent Restenosis Post-Approval Study
Post-Approval Study of the GORE® VIABAHN® Endoprosthesis for the Treatment of In-Stent Restenosis (ISR) in the Superficial Femoral Artery (SFA)
Status: Enrolling
Updated:  12/31/1969
New York University Langone Medical Center
mi
from
New York, NY
In-Stent Restenosis Post-Approval Study
Post-Approval Study of the GORE® VIABAHN® Endoprosthesis for the Treatment of In-Stent Restenosis (ISR) in the Superficial Femoral Artery (SFA)
Status: Enrolling
Updated: 12/31/1969
New York University Langone Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
In-Stent Restenosis Post-Approval Study
Post-Approval Study of the GORE® VIABAHN® Endoprosthesis for the Treatment of In-Stent Restenosis (ISR) in the Superficial Femoral Artery (SFA)
Status: Enrolling
Updated:  12/31/1969
St. Vincent's Consultants in Cardiovascular Disease
mi
from
Erie, PA
In-Stent Restenosis Post-Approval Study
Post-Approval Study of the GORE® VIABAHN® Endoprosthesis for the Treatment of In-Stent Restenosis (ISR) in the Superficial Femoral Artery (SFA)
Status: Enrolling
Updated: 12/31/1969
St. Vincent's Consultants in Cardiovascular Disease
mi
from
Erie, PA
Click here to add this to my saved trials
In-Stent Restenosis Post-Approval Study
Post-Approval Study of the GORE® VIABAHN® Endoprosthesis for the Treatment of In-Stent Restenosis (ISR) in the Superficial Femoral Artery (SFA)
Status: Enrolling
Updated:  12/31/1969
Miriam Hospital
mi
from
Providence, RI
In-Stent Restenosis Post-Approval Study
Post-Approval Study of the GORE® VIABAHN® Endoprosthesis for the Treatment of In-Stent Restenosis (ISR) in the Superficial Femoral Artery (SFA)
Status: Enrolling
Updated: 12/31/1969
Miriam Hospital
mi
from
Providence, RI
Click here to add this to my saved trials
In-Stent Restenosis Post-Approval Study
Post-Approval Study of the GORE® VIABAHN® Endoprosthesis for the Treatment of In-Stent Restenosis (ISR) in the Superficial Femoral Artery (SFA)
Status: Enrolling
Updated:  12/31/1969
Swedish Medical Center - Heart and Vascular Research
mi
from
Seattle, WA
In-Stent Restenosis Post-Approval Study
Post-Approval Study of the GORE® VIABAHN® Endoprosthesis for the Treatment of In-Stent Restenosis (ISR) in the Superficial Femoral Artery (SFA)
Status: Enrolling
Updated: 12/31/1969
Swedish Medical Center - Heart and Vascular Research
mi
from
Seattle, WA
Click here to add this to my saved trials
In-Stent Restenosis Post-Approval Study
Post-Approval Study of the GORE® VIABAHN® Endoprosthesis for the Treatment of In-Stent Restenosis (ISR) in the Superficial Femoral Artery (SFA)
Status: Enrolling
Updated:  12/31/1969
Mount Sinai Medical Center
mi
from
Miami, FL
In-Stent Restenosis Post-Approval Study
Post-Approval Study of the GORE® VIABAHN® Endoprosthesis for the Treatment of In-Stent Restenosis (ISR) in the Superficial Femoral Artery (SFA)
Status: Enrolling
Updated: 12/31/1969
Mount Sinai Medical Center
mi
from
Miami, FL
Click here to add this to my saved trials
In-Stent Restenosis Post-Approval Study
Post-Approval Study of the GORE® VIABAHN® Endoprosthesis for the Treatment of In-Stent Restenosis (ISR) in the Superficial Femoral Artery (SFA)
Status: Enrolling
Updated:  12/31/1969
Kaiser Foundation Hospital
mi
from
Honolulu, HI
In-Stent Restenosis Post-Approval Study
Post-Approval Study of the GORE® VIABAHN® Endoprosthesis for the Treatment of In-Stent Restenosis (ISR) in the Superficial Femoral Artery (SFA)
Status: Enrolling
Updated: 12/31/1969
Kaiser Foundation Hospital
mi
from
Honolulu, HI
Click here to add this to my saved trials
In-Stent Restenosis Post-Approval Study
Post-Approval Study of the GORE® VIABAHN® Endoprosthesis for the Treatment of In-Stent Restenosis (ISR) in the Superficial Femoral Artery (SFA)
Status: Enrolling
Updated:  12/31/1969
University of Iowa Hospitals and Clinics
mi
from
Iowa City, IA
In-Stent Restenosis Post-Approval Study
Post-Approval Study of the GORE® VIABAHN® Endoprosthesis for the Treatment of In-Stent Restenosis (ISR) in the Superficial Femoral Artery (SFA)
Status: Enrolling
Updated: 12/31/1969
University of Iowa Hospitals and Clinics
mi
from
Iowa City, IA
Click here to add this to my saved trials
In-Stent Restenosis Post-Approval Study
Post-Approval Study of the GORE® VIABAHN® Endoprosthesis for the Treatment of In-Stent Restenosis (ISR) in the Superficial Femoral Artery (SFA)
Status: Enrolling
Updated:  12/31/1969
Covenant Medical Center
mi
from
Saginaw, MI
In-Stent Restenosis Post-Approval Study
Post-Approval Study of the GORE® VIABAHN® Endoprosthesis for the Treatment of In-Stent Restenosis (ISR) in the Superficial Femoral Artery (SFA)
Status: Enrolling
Updated: 12/31/1969
Covenant Medical Center
mi
from
Saginaw, MI
Click here to add this to my saved trials
In-Stent Restenosis Post-Approval Study
Post-Approval Study of the GORE® VIABAHN® Endoprosthesis for the Treatment of In-Stent Restenosis (ISR) in the Superficial Femoral Artery (SFA)
Status: Enrolling
Updated:  12/31/1969
University at Buffalo Endovascular/Vascular Surgery
mi
from
Buffalo, NY
In-Stent Restenosis Post-Approval Study
Post-Approval Study of the GORE® VIABAHN® Endoprosthesis for the Treatment of In-Stent Restenosis (ISR) in the Superficial Femoral Artery (SFA)
Status: Enrolling
Updated: 12/31/1969
University at Buffalo Endovascular/Vascular Surgery
mi
from
Buffalo, NY
Click here to add this to my saved trials
In-Stent Restenosis Post-Approval Study
Post-Approval Study of the GORE® VIABAHN® Endoprosthesis for the Treatment of In-Stent Restenosis (ISR) in the Superficial Femoral Artery (SFA)
Status: Enrolling
Updated:  12/31/1969
Providence Heart Clinic
mi
from
Portland, OR
In-Stent Restenosis Post-Approval Study
Post-Approval Study of the GORE® VIABAHN® Endoprosthesis for the Treatment of In-Stent Restenosis (ISR) in the Superficial Femoral Artery (SFA)
Status: Enrolling
Updated: 12/31/1969
Providence Heart Clinic
mi
from
Portland, OR
Click here to add this to my saved trials
In-Stent Restenosis Post-Approval Study
Post-Approval Study of the GORE® VIABAHN® Endoprosthesis for the Treatment of In-Stent Restenosis (ISR) in the Superficial Femoral Artery (SFA)
Status: Enrolling
Updated:  12/31/1969
North Carolina Heart and Vascular
mi
from
Raleigh, NC
In-Stent Restenosis Post-Approval Study
Post-Approval Study of the GORE® VIABAHN® Endoprosthesis for the Treatment of In-Stent Restenosis (ISR) in the Superficial Femoral Artery (SFA)
Status: Enrolling
Updated: 12/31/1969
North Carolina Heart and Vascular
mi
from
Raleigh, NC
Click here to add this to my saved trials
In-Stent Restenosis Post-Approval Study
Post-Approval Study of the GORE® VIABAHN® Endoprosthesis for the Treatment of In-Stent Restenosis (ISR) in the Superficial Femoral Artery (SFA)
Status: Enrolling
Updated:  12/31/1969
Klinikum Rosenheim
mi
from
Rosenheim,
In-Stent Restenosis Post-Approval Study
Post-Approval Study of the GORE® VIABAHN® Endoprosthesis for the Treatment of In-Stent Restenosis (ISR) in the Superficial Femoral Artery (SFA)
Status: Enrolling
Updated: 12/31/1969
Klinikum Rosenheim
mi
from
Rosenheim,
Click here to add this to my saved trials
In-Stent Restenosis Post-Approval Study
Post-Approval Study of the GORE® VIABAHN® Endoprosthesis for the Treatment of In-Stent Restenosis (ISR) in the Superficial Femoral Artery (SFA)
Status: Enrolling
Updated:  12/31/1969
St. Luke's Medical Center
mi
from
Phoenix, AZ
In-Stent Restenosis Post-Approval Study
Post-Approval Study of the GORE® VIABAHN® Endoprosthesis for the Treatment of In-Stent Restenosis (ISR) in the Superficial Femoral Artery (SFA)
Status: Enrolling
Updated: 12/31/1969
St. Luke's Medical Center
mi
from
Phoenix, AZ
Click here to add this to my saved trials
In-Stent Restenosis Post-Approval Study
Post-Approval Study of the GORE® VIABAHN® Endoprosthesis for the Treatment of In-Stent Restenosis (ISR) in the Superficial Femoral Artery (SFA)
Status: Enrolling
Updated:  12/31/1969
Midwest Aortic and Vascular Institute (MAVI)
mi
from
North Kansas City, MO
In-Stent Restenosis Post-Approval Study
Post-Approval Study of the GORE® VIABAHN® Endoprosthesis for the Treatment of In-Stent Restenosis (ISR) in the Superficial Femoral Artery (SFA)
Status: Enrolling
Updated: 12/31/1969
Midwest Aortic and Vascular Institute (MAVI)
mi
from
North Kansas City, MO
Click here to add this to my saved trials
In-Stent Restenosis Post-Approval Study
Post-Approval Study of the GORE® VIABAHN® Endoprosthesis for the Treatment of In-Stent Restenosis (ISR) in the Superficial Femoral Artery (SFA)
Status: Enrolling
Updated:  12/31/1969
New York Presbyterian Hospital-Weill Cornell Medical Center
mi
from
New York, NY
In-Stent Restenosis Post-Approval Study
Post-Approval Study of the GORE® VIABAHN® Endoprosthesis for the Treatment of In-Stent Restenosis (ISR) in the Superficial Femoral Artery (SFA)
Status: Enrolling
Updated: 12/31/1969
New York Presbyterian Hospital-Weill Cornell Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
In-Stent Restenosis Post-Approval Study
Post-Approval Study of the GORE® VIABAHN® Endoprosthesis for the Treatment of In-Stent Restenosis (ISR) in the Superficial Femoral Artery (SFA)
Status: Enrolling
Updated:  12/31/1969
Sanford Health
mi
from
Fargo, ND
In-Stent Restenosis Post-Approval Study
Post-Approval Study of the GORE® VIABAHN® Endoprosthesis for the Treatment of In-Stent Restenosis (ISR) in the Superficial Femoral Artery (SFA)
Status: Enrolling
Updated: 12/31/1969
Sanford Health
mi
from
Fargo, ND
Click here to add this to my saved trials
In-Stent Restenosis Post-Approval Study
Post-Approval Study of the GORE® VIABAHN® Endoprosthesis for the Treatment of In-Stent Restenosis (ISR) in the Superficial Femoral Artery (SFA)
Status: Enrolling
Updated:  12/31/1969
Texas Health Research - Presbyterian Heart and Vascular
mi
from
Dallas, TX
In-Stent Restenosis Post-Approval Study
Post-Approval Study of the GORE® VIABAHN® Endoprosthesis for the Treatment of In-Stent Restenosis (ISR) in the Superficial Femoral Artery (SFA)
Status: Enrolling
Updated: 12/31/1969
Texas Health Research - Presbyterian Heart and Vascular
mi
from
Dallas, TX
Click here to add this to my saved trials
In-Stent Restenosis Post-Approval Study
Post-Approval Study of the GORE® VIABAHN® Endoprosthesis for the Treatment of In-Stent Restenosis (ISR) in the Superficial Femoral Artery (SFA)
Status: Enrolling
Updated:  12/31/1969
Texas Health Research - Presbyterian Hospital of Plano
mi
from
Plano, TX
In-Stent Restenosis Post-Approval Study
Post-Approval Study of the GORE® VIABAHN® Endoprosthesis for the Treatment of In-Stent Restenosis (ISR) in the Superficial Femoral Artery (SFA)
Status: Enrolling
Updated: 12/31/1969
Texas Health Research - Presbyterian Hospital of Plano
mi
from
Plano, TX
Click here to add this to my saved trials
In-Stent Restenosis Post-Approval Study
Post-Approval Study of the GORE® VIABAHN® Endoprosthesis for the Treatment of In-Stent Restenosis (ISR) in the Superficial Femoral Artery (SFA)
Status: Enrolling
Updated:  12/31/1969
Charleston Area Medical Center
mi
from
Charleston, WV
In-Stent Restenosis Post-Approval Study
Post-Approval Study of the GORE® VIABAHN® Endoprosthesis for the Treatment of In-Stent Restenosis (ISR) in the Superficial Femoral Artery (SFA)
Status: Enrolling
Updated: 12/31/1969
Charleston Area Medical Center
mi
from
Charleston, WV
Click here to add this to my saved trials
Medtronic Resolute Onyx 2.0 mm Clinical Study
A Clinical Evaluation of the Medtronic Resolute Onyx Zotarolimus-Eluting 2.0 mm Stent Resolute Onyx 2.0 mm Clinical Study
Status: Enrolling
Updated:  12/31/1969
Scripps Green Hospital
mi
from
La Jolla, CA
Medtronic Resolute Onyx 2.0 mm Clinical Study
A Clinical Evaluation of the Medtronic Resolute Onyx Zotarolimus-Eluting 2.0 mm Stent Resolute Onyx 2.0 mm Clinical Study
Status: Enrolling
Updated: 12/31/1969
Scripps Green Hospital
mi
from
La Jolla, CA
Click here to add this to my saved trials
Medtronic Resolute Onyx 2.0 mm Clinical Study
A Clinical Evaluation of the Medtronic Resolute Onyx Zotarolimus-Eluting 2.0 mm Stent Resolute Onyx 2.0 mm Clinical Study
Status: Enrolling
Updated:  12/31/1969
Morton Plant Hospital
mi
from
Clearwater, FL
Medtronic Resolute Onyx 2.0 mm Clinical Study
A Clinical Evaluation of the Medtronic Resolute Onyx Zotarolimus-Eluting 2.0 mm Stent Resolute Onyx 2.0 mm Clinical Study
Status: Enrolling
Updated: 12/31/1969
Morton Plant Hospital
mi
from
Clearwater, FL
Click here to add this to my saved trials
Medtronic Resolute Onyx 2.0 mm Clinical Study
A Clinical Evaluation of the Medtronic Resolute Onyx Zotarolimus-Eluting 2.0 mm Stent Resolute Onyx 2.0 mm Clinical Study
Status: Enrolling
Updated:  12/31/1969
Saint John's Hospital
mi
from
Springfield, IL
Medtronic Resolute Onyx 2.0 mm Clinical Study
A Clinical Evaluation of the Medtronic Resolute Onyx Zotarolimus-Eluting 2.0 mm Stent Resolute Onyx 2.0 mm Clinical Study
Status: Enrolling
Updated: 12/31/1969
Saint John's Hospital
mi
from
Springfield, IL
Click here to add this to my saved trials
Medtronic Resolute Onyx 2.0 mm Clinical Study
A Clinical Evaluation of the Medtronic Resolute Onyx Zotarolimus-Eluting 2.0 mm Stent Resolute Onyx 2.0 mm Clinical Study
Status: Enrolling
Updated:  12/31/1969
St. Vincent Heart Center of Indiana
mi
from
Indianapolis, IN
Medtronic Resolute Onyx 2.0 mm Clinical Study
A Clinical Evaluation of the Medtronic Resolute Onyx Zotarolimus-Eluting 2.0 mm Stent Resolute Onyx 2.0 mm Clinical Study
Status: Enrolling
Updated: 12/31/1969
St. Vincent Heart Center of Indiana
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Medtronic Resolute Onyx 2.0 mm Clinical Study
A Clinical Evaluation of the Medtronic Resolute Onyx Zotarolimus-Eluting 2.0 mm Stent Resolute Onyx 2.0 mm Clinical Study
Status: Enrolling
Updated:  12/31/1969
Mount Sinai Hospital
mi
from
New York, NY
Medtronic Resolute Onyx 2.0 mm Clinical Study
A Clinical Evaluation of the Medtronic Resolute Onyx Zotarolimus-Eluting 2.0 mm Stent Resolute Onyx 2.0 mm Clinical Study
Status: Enrolling
Updated: 12/31/1969
Mount Sinai Hospital
mi
from
New York, NY
Click here to add this to my saved trials
Medtronic Resolute Onyx 2.0 mm Clinical Study
A Clinical Evaluation of the Medtronic Resolute Onyx Zotarolimus-Eluting 2.0 mm Stent Resolute Onyx 2.0 mm Clinical Study
Status: Enrolling
Updated:  12/31/1969
Saint Francis Hospital
mi
from
Roslyn, NY
Medtronic Resolute Onyx 2.0 mm Clinical Study
A Clinical Evaluation of the Medtronic Resolute Onyx Zotarolimus-Eluting 2.0 mm Stent Resolute Onyx 2.0 mm Clinical Study
Status: Enrolling
Updated: 12/31/1969
Saint Francis Hospital
mi
from
Roslyn, NY
Click here to add this to my saved trials
Medtronic Resolute Onyx 2.0 mm Clinical Study
A Clinical Evaluation of the Medtronic Resolute Onyx Zotarolimus-Eluting 2.0 mm Stent Resolute Onyx 2.0 mm Clinical Study
Status: Enrolling
Updated:  12/31/1969
Duke Univ Med Ctr
mi
from
Durham, NC
Medtronic Resolute Onyx 2.0 mm Clinical Study
A Clinical Evaluation of the Medtronic Resolute Onyx Zotarolimus-Eluting 2.0 mm Stent Resolute Onyx 2.0 mm Clinical Study
Status: Enrolling
Updated: 12/31/1969
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
Medtronic Resolute Onyx 2.0 mm Clinical Study
A Clinical Evaluation of the Medtronic Resolute Onyx Zotarolimus-Eluting 2.0 mm Stent Resolute Onyx 2.0 mm Clinical Study
Status: Enrolling
Updated:  12/31/1969
Sanford Medical Center
mi
from
Fargo, ND
Medtronic Resolute Onyx 2.0 mm Clinical Study
A Clinical Evaluation of the Medtronic Resolute Onyx Zotarolimus-Eluting 2.0 mm Stent Resolute Onyx 2.0 mm Clinical Study
Status: Enrolling
Updated: 12/31/1969
Sanford Medical Center
mi
from
Fargo, ND
Click here to add this to my saved trials
Medtronic Resolute Onyx 2.0 mm Clinical Study
A Clinical Evaluation of the Medtronic Resolute Onyx Zotarolimus-Eluting 2.0 mm Stent Resolute Onyx 2.0 mm Clinical Study
Status: Enrolling
Updated:  12/31/1969
University Hospitals Elyria Medical Center
mi
from
Elyria, OH
Medtronic Resolute Onyx 2.0 mm Clinical Study
A Clinical Evaluation of the Medtronic Resolute Onyx Zotarolimus-Eluting 2.0 mm Stent Resolute Onyx 2.0 mm Clinical Study
Status: Enrolling
Updated: 12/31/1969
University Hospitals Elyria Medical Center
mi
from
Elyria, OH
Click here to add this to my saved trials
Medtronic Resolute Onyx 2.0 mm Clinical Study
A Clinical Evaluation of the Medtronic Resolute Onyx Zotarolimus-Eluting 2.0 mm Stent Resolute Onyx 2.0 mm Clinical Study
Status: Enrolling
Updated:  12/31/1969
Geisinger Medical Center
mi
from
Danville, PA
Medtronic Resolute Onyx 2.0 mm Clinical Study
A Clinical Evaluation of the Medtronic Resolute Onyx Zotarolimus-Eluting 2.0 mm Stent Resolute Onyx 2.0 mm Clinical Study
Status: Enrolling
Updated: 12/31/1969
Geisinger Medical Center
mi
from
Danville, PA
Click here to add this to my saved trials
Medtronic Resolute Onyx 2.0 mm Clinical Study
A Clinical Evaluation of the Medtronic Resolute Onyx Zotarolimus-Eluting 2.0 mm Stent Resolute Onyx 2.0 mm Clinical Study
Status: Enrolling
Updated:  12/31/1969
AnMed Health Medical Center
mi
from
Anderson, SC
Medtronic Resolute Onyx 2.0 mm Clinical Study
A Clinical Evaluation of the Medtronic Resolute Onyx Zotarolimus-Eluting 2.0 mm Stent Resolute Onyx 2.0 mm Clinical Study
Status: Enrolling
Updated: 12/31/1969
AnMed Health Medical Center
mi
from
Anderson, SC
Click here to add this to my saved trials
Medtronic Resolute Onyx 2.0 mm Clinical Study
A Clinical Evaluation of the Medtronic Resolute Onyx Zotarolimus-Eluting 2.0 mm Stent Resolute Onyx 2.0 mm Clinical Study
Status: Enrolling
Updated:  12/31/1969
Centennial Medical Center
mi
from
Nashville, TN
Medtronic Resolute Onyx 2.0 mm Clinical Study
A Clinical Evaluation of the Medtronic Resolute Onyx Zotarolimus-Eluting 2.0 mm Stent Resolute Onyx 2.0 mm Clinical Study
Status: Enrolling
Updated: 12/31/1969
Centennial Medical Center
mi
from
Nashville, TN
Click here to add this to my saved trials
Medtronic Resolute Onyx 2.0 mm Clinical Study
A Clinical Evaluation of the Medtronic Resolute Onyx Zotarolimus-Eluting 2.0 mm Stent Resolute Onyx 2.0 mm Clinical Study
Status: Enrolling
Updated:  12/31/1969
Dallas VA Medical Center
mi
from
Dallas, TX
Medtronic Resolute Onyx 2.0 mm Clinical Study
A Clinical Evaluation of the Medtronic Resolute Onyx Zotarolimus-Eluting 2.0 mm Stent Resolute Onyx 2.0 mm Clinical Study
Status: Enrolling
Updated: 12/31/1969
Dallas VA Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Medtronic Resolute Onyx 2.0 mm Clinical Study
A Clinical Evaluation of the Medtronic Resolute Onyx Zotarolimus-Eluting 2.0 mm Stent Resolute Onyx 2.0 mm Clinical Study
Status: Enrolling
Updated:  12/31/1969
East Texas Medical Center
mi
from
Tyler, TX
Medtronic Resolute Onyx 2.0 mm Clinical Study
A Clinical Evaluation of the Medtronic Resolute Onyx Zotarolimus-Eluting 2.0 mm Stent Resolute Onyx 2.0 mm Clinical Study
Status: Enrolling
Updated: 12/31/1969
East Texas Medical Center
mi
from
Tyler, TX
Click here to add this to my saved trials
Medtronic Resolute Onyx 2.0 mm Clinical Study
A Clinical Evaluation of the Medtronic Resolute Onyx Zotarolimus-Eluting 2.0 mm Stent Resolute Onyx 2.0 mm Clinical Study
Status: Enrolling
Updated:  12/31/1969
NYU Langone Medical Center
mi
from
New York, NY
Medtronic Resolute Onyx 2.0 mm Clinical Study
A Clinical Evaluation of the Medtronic Resolute Onyx Zotarolimus-Eluting 2.0 mm Stent Resolute Onyx 2.0 mm Clinical Study
Status: Enrolling
Updated: 12/31/1969
NYU Langone Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Medtronic Resolute Onyx 2.0 mm Clinical Study
A Clinical Evaluation of the Medtronic Resolute Onyx Zotarolimus-Eluting 2.0 mm Stent Resolute Onyx 2.0 mm Clinical Study
Status: Enrolling
Updated:  12/31/1969
Lankenau Medical Center
mi
from
Wynnewood, PA
Medtronic Resolute Onyx 2.0 mm Clinical Study
A Clinical Evaluation of the Medtronic Resolute Onyx Zotarolimus-Eluting 2.0 mm Stent Resolute Onyx 2.0 mm Clinical Study
Status: Enrolling
Updated: 12/31/1969
Lankenau Medical Center
mi
from
Wynnewood, PA
Click here to add this to my saved trials
Medtronic Resolute Onyx 2.0 mm Clinical Study
A Clinical Evaluation of the Medtronic Resolute Onyx Zotarolimus-Eluting 2.0 mm Stent Resolute Onyx 2.0 mm Clinical Study
Status: Enrolling
Updated:  12/31/1969
Barnes Jewish University
mi
from
Saint Louis, MO
Medtronic Resolute Onyx 2.0 mm Clinical Study
A Clinical Evaluation of the Medtronic Resolute Onyx Zotarolimus-Eluting 2.0 mm Stent Resolute Onyx 2.0 mm Clinical Study
Status: Enrolling
Updated: 12/31/1969
Barnes Jewish University
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Medtronic RESOLUTE ONYX Core (2.25 mm - 4.0 mm) Clinical Study
A Clinical Evaluation of the Medtronic Resolute Onyx Zotarolimus-Eluting Stent System Medtronic RESOLUTE ONYX Core (2.25 mm - 4.0 mm) Clinical Study
Status: Enrolling
Updated:  12/31/1969
Scripps Green Hospital
mi
from
La Jolla, CA
Medtronic RESOLUTE ONYX Core (2.25 mm - 4.0 mm) Clinical Study
A Clinical Evaluation of the Medtronic Resolute Onyx Zotarolimus-Eluting Stent System Medtronic RESOLUTE ONYX Core (2.25 mm - 4.0 mm) Clinical Study
Status: Enrolling
Updated: 12/31/1969
Scripps Green Hospital
mi
from
La Jolla, CA
Click here to add this to my saved trials
Medtronic RESOLUTE ONYX Core (2.25 mm - 4.0 mm) Clinical Study
A Clinical Evaluation of the Medtronic Resolute Onyx Zotarolimus-Eluting Stent System Medtronic RESOLUTE ONYX Core (2.25 mm - 4.0 mm) Clinical Study
Status: Enrolling
Updated:  12/31/1969
Morton Plant Hospital
mi
from
Clearwater, FL
Medtronic RESOLUTE ONYX Core (2.25 mm - 4.0 mm) Clinical Study
A Clinical Evaluation of the Medtronic Resolute Onyx Zotarolimus-Eluting Stent System Medtronic RESOLUTE ONYX Core (2.25 mm - 4.0 mm) Clinical Study
Status: Enrolling
Updated: 12/31/1969
Morton Plant Hospital
mi
from
Clearwater, FL
Click here to add this to my saved trials
Medtronic RESOLUTE ONYX Core (2.25 mm - 4.0 mm) Clinical Study
A Clinical Evaluation of the Medtronic Resolute Onyx Zotarolimus-Eluting Stent System Medtronic RESOLUTE ONYX Core (2.25 mm - 4.0 mm) Clinical Study
Status: Enrolling
Updated:  12/31/1969
Saint John's Hospital
mi
from
Springfield, IL
Medtronic RESOLUTE ONYX Core (2.25 mm - 4.0 mm) Clinical Study
A Clinical Evaluation of the Medtronic Resolute Onyx Zotarolimus-Eluting Stent System Medtronic RESOLUTE ONYX Core (2.25 mm - 4.0 mm) Clinical Study
Status: Enrolling
Updated: 12/31/1969
Saint John's Hospital
mi
from
Springfield, IL
Click here to add this to my saved trials
Medtronic RESOLUTE ONYX Core (2.25 mm - 4.0 mm) Clinical Study
A Clinical Evaluation of the Medtronic Resolute Onyx Zotarolimus-Eluting Stent System Medtronic RESOLUTE ONYX Core (2.25 mm - 4.0 mm) Clinical Study
Status: Enrolling
Updated:  12/31/1969
St. Vincent Heart Center of Indiana
mi
from
Indianapolis, IN
Medtronic RESOLUTE ONYX Core (2.25 mm - 4.0 mm) Clinical Study
A Clinical Evaluation of the Medtronic Resolute Onyx Zotarolimus-Eluting Stent System Medtronic RESOLUTE ONYX Core (2.25 mm - 4.0 mm) Clinical Study
Status: Enrolling
Updated: 12/31/1969
St. Vincent Heart Center of Indiana
mi
from
Indianapolis, IN
Click here to add this to my saved trials